A diagnostic protein assay for differentiating follicular thyroid adenoma and carcinoma
Yaoting Sun,He Wang,Lu Li,Jianbiao Wang,Wanyuan Chen,Li Peng,Pingping Hu,Jing Yu,Xue Cai,Nan Yao,Yan Zhou,Jiatong Wang,Yingrui Wang,Liqin Qian,Weigang Ge,Mengni Chen,Feng Yang,Zhiqiang Gui,Wei Sun,Zhihong Wang,Minghua Ge,Yi He,Guangzhi Wang,Yongfu Zhao,Huanjie Chen,Xiaohong Wu,Yuxin Du,Wenjun Wei,Fan Wu,Dingcun Luo,Xiangfeng Lin,Haitao Zheng,Xin Zhu,Bei Wei,Jiafei Shen,Jincao Yao,Zhennan Yuan,Tong Liu,Jun Pan,Yifeng Zhang,Yangfan Lv,Qiaonan Guo,Qijun Wu,Tingting Gong,Ting Chen,Shu Zheng,Jingqiang Zhu,Hanqing Liu,Chuang Chen,Hong Han,Sathiyamoorthy Selvarajan,Mingzhao Xing,Kennichi Kakudo,Erik K. Alexander,Yijun Wu,Yu Wang,Dong Xu,Hao Zhang,Xiu Nie,Oi Lian Kon,N. Gopalakrishna Iyer,Zhiyan Liu,Yi Zhu,Haixia Guan,Tiannan Guo,We-TEC Consortium
DOI: https://doi.org/10.1101/2024.09.26.24314403
2024-09-26
Abstract:Differentiating follicular thyroid adenoma (FTA) from carcinoma (FTC) remains challenging due to similar histological features separate from invasion. In this study, we aim to develop and validate DNA and protein-based classifiers for FTA/FTC differentiation. We collected 2443 samples from 1568 patients across 24 centers and applied next-generation sequencing, as well as discovery and targeted proteomics. Machine learning models were developed and compared utilizing DNA and/or protein features. The discovery protein-based model (AUC 0.899) outperformed the gene-based model (AUC 0.670). Consequently, we generated a protein-based model with targeted mass spectrometry and further validated it in three independent testing sets. The 24-protein-based model achieved high performance in the retrospective sets (AUC 0.871 and 0.853) and the prospective fine-needle aspiration biopsies (AUC 0.781). The classifier notably illustrated a 95.7% negative predictive value for ruling out malignant nodules. This study offers a promising protein-based approach for differential diagnosis of FTA and FTC.
Oncology